Product Catalog



PTX3 / TNFAIP5 Protein (His Tag) (Cytokine)
| Catalog | Size (Price) | Quantity | In Stock | Operation | Other Information |
| 12082-H08H |
|
YES |
|
![]() |
|
Pentraxin-Related Protein PTX3 Protein
PTX3 / TNFAIP5 / TSG-14 Protein Price Inquiry ( Available Sizes )
- 200μg: Inquiring Price;
- ≥1mg Bulk: Inquiring Price
PTX3 / TNFAIP5 / TSG-14 Protein Product Information
| Synonym : |
PTX3, TNFAIP5, TSG-14 |
| Protein Construction: |
A DNA sequence encoding the human PTX3 ( NP_002843.2 ) ( Met 1 - Ser 381 ) was fused with a polyhistidine tag at the C-terminus |
| Source: | Human |
| Expression Host: | Human Cells |
PTX3 / TNFAIP5 / TSG-14 Protein QC Testing
| Purity: | > 97 % as determined by SDS-PAGE | SDS-PAGE:![]() PTX3 protein |
| Endotoxin: | < 1.0 EU per μg of the protein as determined by the LAL method | |
| Stability: | Samples are stable for up to twelve months from date of receipt at -70℃ | |
| Predicted N terminal: | Glu 18 | |
| Molecular Mass: |
The secreted recombinant human PTX3 consists of 375 amino acids and has a predicted molecular mass of 41.6 kDa. In SDS-PAGE under reducing conditions, the apparent molecular mass of the protein is approximately 43 - 47 kDa. |
|
| Formulation: | Lyophilized from sterile PBS , pH 7.4
|
PTX3 / TNFAIP5 / TSG-14 Protein Usage Guide
| Storage: | Store it under sterile conditions at -70℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles. |
| Reconstitution: | A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information. |
PTX3 / TNFAIP5 / TSG-14 Protein Related Products & Topics
Related Areas:
Immunology>>Innate Immunity>>Acute Phase Proteins>>PTX3/Pentraxin 3/TSG-14
Proteins:
| Molecule | Species | Description //For Detailed Info. and Price------CLICK! | Cat. No |
| PTX3/Pentraxin 3/TSG-14 | Human | PTX3/Pentraxin 3/TSG-14 Protein, Recombinant | 12082-H08H |
Antibodies:
| Molecule | Application | Description //For Detailed Info. and Price------CLICK! | Cat. No |
| Human PTX3/Pentraxin 3/TSG-14 | WB, ELISA | PTX3 / Pentraxin 3 / TSG-14 Antibody | 12082-RP01 |
| Human PTX3/Pentraxin 3/TSG-14 | WB, ELISA | PTX3 / Pentraxin 3 / TSG-14 Antibody (Antigen Affinity Purified) | 12082-RP02 |
| Human PTX3/Pentraxin 3/TSG-14 | WB, ELISA | PTX3 / Pentraxin 3 / TSG-14 Antibody | 12082-MM01 |
PTX3 / TNFAIP5 / TSG-14 Protein Description
Pentraxin-related protein PTX3, also known as Tumor necrosis factor alpha-induced protein 5, Tumor necrosis factor-inducible gene 14 protein, TSG-14, PTX3 and TNFAIP5, is a secreted protein which contains one pentaxin domain. PTX3 plays a role in the regulation of innate resistance to pathogens, inflammatory reactions, possibly clearance of self-components and female fertility. Pentraxins are a family of evolutionarily conserved multifunctional pattern-recognition proteins characterized by a cyclic multimeric structure. Based on the primary structure of the subunit, the pentraxins are divided into two groups: short pentraxins and long pentraxins. C-reactive protein (CRP) and serum amyloid P-component (SAP) are the two short pentraxins. The prototype protein of the long pentraxin group is pentraxin 3 (PTX3). CRP and SAP are produced primarily in the liver in response to IL-6, while PTX3 is produced by a variety of tissues and cells and in particular by innate immunity cells in response to proinflammatory signals and Toll-like receptor (TLR) engagement. PTX3 is essential in female fertility by acting as a nodal point for the assembly of the cumulus oophorus hyaluronan-rich extracellular matrix. PTX3 interacts with several ligands, including growth factors, extracellular matrix components and selected pathogens, playing a role in complement activation and facilitating pathogen recognition by phagocytes, acting as a predecessor of antibodies. PTX3 may also contribute to the pathogenesis of atherosclerosis.
References
- Rolph,M.S. et al., 2002, Arterioscler Thromb Vasc Biol. 22 (5):e10-4.
- Mantovani A., et al., 2003, Vaccine. 21:S43-S47.
- Luchetti,M.M. et al., 2004, Clin Exp Rheumatol. 22 (3):S66-72.
- Mantovani, A. et al., 2006, Vascul Pharmacol. 45 (5):326-30.
- Inforzato A., et al., 2008, J. Biol. Chem. 283:10147-61.
+86-400-890-9989







